Trilations Healthcare Strategies’ Post

So you get a new Medical Strategy, now what? How do you translate that into decision-grade insights? This is an area that many #MSLs get stuck on. How can you translate this into steps that result in gathering insights that your company gets all googly-eyed over? Learn how to go from Medical Strategy to MSL Insights in this upcoming 30-minute webinar on May 9 @ 12 pm PT! Richard Swank, Ph.D. and I will be covering: 🎯How to think about a corporate strategy 🎯How corporate strategy gets translated into medical strategy 🎯A framework to prioritize insights gathering based on Medical Strategy Register using the link in the comments and repost to your network to help your #medicalaffairs friends better execute on strategy! See you on May 9! #medicalexcellence #MSLinsights

So you get a new Medical Strategy, now what? How do you translate that into decision-grade insights? This is an area that many #MSLs get stuck on. How can you translate this into steps that result in gathering insights that your company gets all googly-eyed over? Learn how to go from Medical Strategy to MSL Insights in this upcoming 30-minute webinar on May 9 @ 12 pm PT! Rich Swank and I will be covering: 🎯How to think about a corporate strategy 🎯How corporate strategy gets translated into medical strategy 🎯A framework to prioritize insights gathering based on Medical Strategy Register using the link in the comments and repost to your network to help your #medicalaffairs friends better execute on strategy! See you on May 9! #medicalexcellence #MSLinsights

𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗡𝗲𝘄 𝗚𝗿𝗼𝘂𝗻𝗱 𝗔𝘁 𝘁𝗵𝗲 𝟮𝟭𝘀𝘁 𝗕𝗶𝗼𝗣𝗵𝗮𝗿𝗺𝗮 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗡𝗲𝘅𝘂𝘀!   Our esteemed panelists are currently diving deep into the discussion on "Successful Integration of Clinical Operations and Medical Affairs for Enhanced Patient Care." What a dynamic and engaging conversation it is! The exchange of ideas and strategies is truly inspiring, highlighting how collaboration in clinical operations and medical affairs can drive impactful patient outcomes. Stay tuned for more insights from the event! #BioPharma #ClinicalTrials #PatientCare #MedicalAffairs #ClinicalOperations #Clinical #NexusConference #Procurementdirect

Discover the pivotal role of Medical Affairs in revolutionizing healthcare! Arshi Gupta delves into the changing dynamics of the industry, emphasizing the indispensable partnership between Medical Affairs teams and drug manufacturers. Explore integrated evidence strategies, medicalized engagement approaches, and more. Elevate your understanding of healthcare delivery and patient outcomes! https://ow.ly/XXkb50QZYU0 #MedicalAffairs #HealthcareTransformation #EvidenceBasedPractice

Medical Affairs teams play a critical role in bridging the gap between scientific innovation and clinical practice. But demonstrating their concrete impact to secure budgets and resources remains a challenge. That's where data-driven insights can have a major impact. We recently helped a biotech company quantify the impact of their Medical Science Liaison (MSL) team by going beyond traditional metrics. By analysing the impact of the team, we provided concrete evidence of their influence on HCPs, scientific discourse and overall business outcomes. This led to a significant budget increase, enabling the company to secure the necessary resources to continue driving innovation and improving patient care. Find out how we did it in our latest case study 👇 https://lnkd.in/eBQVA5Ye #MedicalAffairs #MarketAccess #HealthcareCommunications

For Medical Science Liaisons, avoiding specific pitfalls can enhance both personal credibility and organizational impact. Learn about the common mistakes MSLs make and how to approach KOL engagements and medical strategies with precision. Watch here: https://lnkd.in/d4Grmw2J #MSLCareer #MedicalScienceLiaison #MSL #MedicalAffairs #pharmaceuticalIndustry

We are using robust data analysis to help our med affairs clients make intentional decisions around allocation of resource. Return on investment measurement is a critical part of our strategic planning with clients. #bioscriptgroup #medaffairs #dataandinsight

Discover the pivotal role of Medical Affairs in revolutionizing healthcare! Arshi Gupta delves into the changing dynamics of the industry, emphasizing the indispensable partnership between Medical Affairs teams and drug manufacturers. Explore integrated evidence strategies, medicalized engagement approaches, and more. Elevate your understanding of healthcare delivery and patient outcomes! https://ow.ly/XXkb50QZYU0 #MedicalAffairs #HealthcareTransformation #EvidenceBasedPractice

How can early involvement of Medical Affairs influence which indications should be pursued for a label? We'll dive into this topic TOMORROW in this webinar, with Putnam: "Optimizing Clinical Development Plans Through Earlier Integration of Medical Affairs" with expert speakers Lori Klein, PharmD, John Yee, MD, MPH, & Joseph Elassal MD, MBA! Register for this event HERE: https://lnkd.in/gT_ch4JH #MedicalAffairs #MedAffairs #MAPSEvent #jointhemovement

Tired of wondering if your medical strategy is truly making a difference? 🤔 Let's cut to the chase. Are you really seeing the impact on patients? 🧐 In this #InsightInSixty video, we dive deep into the importance of tracking real-world clinical data. 📊 Discover how your strategy influences actual treatment pathways, access to life-changing therapies, and the quality of life for the patients you serve. 👩⚕️👨⚕️ Join me and APA - Medical Affairs as we explore how patient outcome data can help you: * Identify unmet needs that your strategy might be missing. 🔍 * Refine your approach for even greater impact. 📈 * Ensure your efforts are making a tangible difference in the lives of patients. ❤️ Let's work together to make a real, measurable impact on patient care. 💪 #InisghtInSixty #MedicalAffairs #PatientCentered #PharmaceuticalIndustry #ImpactMatters #MedicalStrategy